Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 1, 2023. (Total: 223516Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Efficiency and CYP2D6[original query]
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
Molecular psychiatry 2008 Jun 13 (6): 597-605.
Schenk P W, van Fessem M A C, Verploegh-Van Rij S, Mathot R A A, van Gelder T, Vulto A G, van Vliet M, Lindemans J, Bruijn J A, van Schaik R H
Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
Pharmacogenomics 2009 Jul 10 (7): 1157-67.
Jannetto Paul J, Bratanow Nancy
The impact of CYP2D6 genetic polymorphisms on postoperative morphine consumption.
Pain medicine (Malden, Mass.) 0 10 (5): 799-805.
Candiotti Keith A, Yang Zongqi, Rodriguez Yiliam, Crescimone Andres, Sanchez Greys C, Takacs Peter, Medina Carlos, Zhang Yanping, Liu Huanliang, Gitlin Melvin
Prevalence of CYP450 gene variations in patients with type 2 diabetes.
Clinical laboratory 2010 56 (7-8): 311-8.
Weise A, Prause S, Eidens M, Weber M M, Kann P H, Forst T, Pfützner
Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
Cell biochemistry and function 2011 Oct 29 (7): 562-8.
Rideg Orsolya, Háber Agota, Botz Lajos, Szücs Ferenc, Várnai Réka, Miseta Attila, Kovács Gábor
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients.
Pharmacogenomics and personalized medicine 2012 5 149-53.
Sirachainan Ekaphop, Jaruhathai Sureerat, Trachu Narumol, Panvichian Ravat, Sirisinha Thitiya, Ativitavas Touch, Ratanatharathorn Vorachai, Chamnanphon Montri, Sukasem Chonlaph
CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.
Pharmacogenomics 2014 Feb 15 (3): 339-48.
Lazalde-Ramos Blanca Patricia, Martínez-Fierro Margarita de la Luz, Galaviz-Hernández Carlos, Garza-Veloz Idalia, Naranjo María Eugenia G, Sosa-Macías Martha, Llerena Adri
Investigation of CYP2D6 Gene Polymorphisms in Turkish Population.
Psychopharmacology bulletin 2016 Mar 46 (1): 67-72.
Taskin Bayram, Percin Ferda E, Ergun Mehmet A
Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations.
Pharmacogenomics and personalized medicine 2017 10 93-99.
Sychev Dmitrij Alekseevitch, Shuev Grigorij Nikolaevich, Suleymanov Salavat Shejhovich, Ryzhikova Kristina Anatol'evna, Mirzaev Karin Badavievich, Grishina Elena Anatol'evna, Snalina Natalia Evgenievna, Sozaeva Zhannet Alimovna, Grabuzdov Anton Mikhailovich, Matsneva Irina Andreev
Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype.
Forensic science international. Genetics 2018 03 33 48-58.
Wendt Frank R, Sajantila Antti, Budowle Bru
Genetic profiles to identify talents in elite endurance athletes and professional football players.
PloS one 2022 17 (9): e0274880.
Varillas-Delgado David, Morencos Esther, Gutiérrez-Hellín Jorge, Aguilar-Navarro Millán, Muñoz Alejandro, Mendoza Láiz Nuria, Perucho Teresa, Maestro Antonio, Tellería-Orriols Juan Jo
TOP